COMBINATION BIOLOGIC THERAPY WITH INTERLEUKIN-2 AND INTERFERON-ALFA IN THE OUTPATIENT TREATMENT OF METASTATIC RENAL-CELL CARCINOMA

被引：0
|
作者：
FIGLIN, RA [1 ]
PIERCE, WC [1 ]
BELLDEGRUN, A [1 ]
机构：
[1] UNIV CALIF LOS ANGELES, SCH MED,JONSSON COMPREHENS CANC CTR,DEPT SURG, DIV UROL, LOS ANGELES, CA 90024 USA
来源：
SEMINARS IN ONCOLOGY | 1993年 / 20卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：11 / 15
页数：5
相关论文
共 50 条
  • [31] Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
    Motzer, Robert J.
    Hutson, Thomas E.
    Tomczak, Piotr
    Michaelson, M. Dror
    Bukowski, Ronald M.
    Rixe, Olivier
    Oudard, Stephane
    Negrier, Sylvie
    Szczylik, Cezary
    Kim, Sindy T.
    Chen, Isan
    Bycott, Paul W.
    Baum, Charles M.
    Figlin, Robert A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02): : 115 - 124
  • [32] RENAL-CELL CARCINOMA - TREATMENT WITH RECOMBINANT INTERLEUKIN-2 PLUS BETA-INTERFERON
    KRIGEL, RL
    PADAVICSHALLER, KA
    RUDOLPH, AR
    KONRAD, M
    BRADLEY, EC
    COMIS, RL
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) : 460 - 467
  • [33] Modest effect of interferon alfa on metastatic renal-cell carcinoma
    Amato, R
    LANCET, 1999, 353 (9146): : 6 - 7
  • [34] METASTATIC RENAL-CELL CARCINOMA PATIENTS TREATED WITH INTERLEUKIN-2 OR INTERLEUKIN-2 PLUS INTERFERON-GAMMA - IMMUNOLOGICAL MONITORING
    FARACE, F
    PALLARDY, M
    ANGEVIN, E
    HERCEND, T
    ESCUDIER, B
    TRIEBEL, F
    INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (06) : 814 - 821
  • [35] INTERFERON THERAPY FOR METASTATIC RENAL-CELL CARCINOMA
    SWANSON, DA
    QUESADA, JR
    SEMINARS IN SURGICAL ONCOLOGY, 1988, 4 (03): : 174 - 177
  • [36] THE ROLE OF INTERFERON AND INTERLEUKIN-2 IN THE IMMUNOTHERAPEUTIC APPROACH TO RENAL-CELL CARCINOMA
    FIGLIN, RA
    ABIAAD, AS
    BELLDEGRUN, A
    DEKERNION, JB
    SEMINARS IN ONCOLOGY, 1991, 18 (05) : 102 - 107
  • [37] Progressive anemia following combination therapy with interferon-α and interleukin-2 in a patient with metastatic renal cell carcinoma
    Hosokawa, Y
    Kishino, T
    Ono, T
    Oyama, N
    Hayashi, K
    Momose, H
    INTERNATIONAL JOURNAL OF UROLOGY, 2004, 11 (10) : 906 - 908
  • [38] INTERLEUKIN-2 IN COMBINATION WITH INTERFERON-ALPHA AND 5-FLUOROURACIL FOR METASTATIC RENAL-CELL CANCER
    ATZPODIEN, J
    KIRCHNER, H
    HANNINEN, EL
    DECKERT, M
    FENNER, M
    POLIWODA, H
    EUROPEAN JOURNAL OF CANCER, 1993, 29A : S6 - S8
  • [39] Monotherapy with interferon-α, or combination therapy with interferon-α, interleukin-2 and 5-fluorouracil for metastatic renal cell carcinoma
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 285 - 285
  • [40] TREATMENT OF METASTATIC RENAL-CELL CARCINOMA WITH AUTOLYMPHOCYTE THERAPY - LOW TOXICITY OUTPATIENT APPROACH TO ADOPTIVE IMMUNOTHERAPY WITHOUT USE OF INVIVO INTERLEUKIN-2
    KRANE, RJ
    CARPINITO, GA
    ROSS, SD
    LAVIN, PT
    OSBAND, ME
    UROLOGY, 1990, 35 (05) : 417 - 422
12345